Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
2012 1
2013 1
2014 3
2015 2
2016 6
2017 3
2018 2
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D'Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Fréchet Jachym M, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Marín Royo M, Mazza-Stalder J, Motta I, Ong CWM, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Zabaleta Murguiondo M, Sotgiu G, Migliori GB. Tadolini M, et al. Among authors: le du d. Eur Respir J. 2020 Jul 9;56(1):2001398. doi: 10.1183/13993003.01398-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32457198 Free PMC article.
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
Guglielmetti L, Jaffré J, Bernard C, Brossier F, El Helali N, Chadelat K, Thouvenin G, Dautzenberg B, Henry B, Jaspard M, Guillot H, Pourcher V, Le Dû D, Marigot-Outtandy D, Mougari F, Raskine L, Rivoire B, Andrejak C, Jarlier V, Aubry A, Robert J, Frechet-Jachym M, Veziris N. Guglielmetti L, et al. Among authors: le du d. Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1050-1054. doi: 10.5588/ijtld.18.0779. Int J Tuberc Lung Dis. 2019. PMID: 31627768
[Adjuvant surgical resection for multidrug-resistant tuberculosis: A review].
Mordant P, Henry B, Morel S, Robert J, Veziris N, Le Dû D, Frechet-Jachym M, Similowski T, Caumes É, Riquet M, Le Pimpec-Barthes F. Mordant P, et al. Among authors: le du d. Rev Mal Respir. 2014 Jun;31(6):511-24. doi: 10.1016/j.rmr.2014.01.014. Epub 2014 Apr 18. Rev Mal Respir. 2014. PMID: 25012037 Review. French.
Bedaquiline plus delamanid for XDR tuberculosis.
Lachâtre M, Rioux C, Le Dû D, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y. Lachâtre M, et al. Among authors: le du d. Lancet Infect Dis. 2016 Mar;16(3):294. doi: 10.1016/S1473-3099(16)00047-5. Lancet Infect Dis. 2016. PMID: 26973310 No abstract available.
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.
Guglielmetti L, Barkane L, Le Dû D, Marigot-Outtandy D, Robert J, Veziris N, Yazdanpanah Y, Kuksa L, Caumes E, Fréchet-Jachym M. Guglielmetti L, et al. Among authors: le du d. Eur Respir J. 2018 Mar 22;51(3):1702550. doi: 10.1183/13993003.02550-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29419439 Free article. No abstract available.
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. de Truchis P, et al. Among authors: le du d. J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434. J Antimicrob Chemother. 2018. PMID: 29186458 Clinical Trial.
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Guglielmetti L, et al. Among authors: le du d. Eur Respir J. 2016 Aug;48(2):582-5. doi: 10.1183/13993003.00411-2016. Epub 2016 Jun 23. Eur Respir J. 2016. PMID: 27338196 Free article. No abstract available.
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A; CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA; CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA. Veziris N, et al. Among authors: le du d. Eur Respir J. 2017 Mar 22;49(3):1601719. doi: 10.1183/13993003.01719-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28182568 Free article. No abstract available.
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.
Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M; French MDR-TB Management Group. Guglielmetti L, et al. Among authors: le du d. Eur Respir J. 2017 Mar 22;49(3):1601799. doi: 10.1183/13993003.01799-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28182570 Free article.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page